Comparing the two most common loci in the western countries, patients with BBS1 mutations are more likely to have either no CKD or mild to moderate CKD, whereas patients with mutations in BBS10 are likely to have severe CKD [53]. This evidence concerns the gene BBS1 and chronic kidney disease.